Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression

Hiu-Fung Yuen, Cian M. McCrudden, Claire Grills, Shu-Dong Zhang, Yu-Han Huang, Ka-Kui Chan, Yuen-Piu Chan, Michelle Lok-Yee Wong, Simon Law, Gopesh Srivastava, Dean A. Fennell, Glenn Dickson, Mohamed El-Tanani, Kwok-Wah Chan

Research output: Contribution to journalArticle

13 Citations (Scopus)
4 Downloads (Pure)
Original languageEnglish
Pages (from-to)1145-1154
JournalCancer Science
Volume103
Issue number6
DOIs
Publication statusPublished - 2012

Keywords

  • BMP6
  • noggin
  • SOST combination
  • prognostic indicator
  • cancer progression
  • prostate
  • bladder and colorectal cancers

Cite this

Yuen, H-F., McCrudden, C. M., Grills, C., Zhang, S-D., Huang, Y-H., Chan, K-K., Chan, Y-P., Wong, M. L-Y., Law, S., Srivastava, G., Fennell, D. A., Dickson, G., El-Tanani, M., & Chan, K-W. (2012). Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression. Cancer Science, 103(6), 1145-1154. https://doi.org/10.1111/j.1349-7006.2012.02252.x